Korea United Pharm Inc.

A033270

KR7033270000

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
25,350 ^KRW	+1.40%		+3.89%	-6.11%

2023	Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	CI
2023	Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	CI

Korea United Pharm Inc. agreed to sell 41% stake in Korea United Bio-Chem Pharmaceutical.

December 22, 2014 at 11:00 pm EST

Korea United Pharm Inc. (KOSE:A033270) agreed to sell 41% stake in Korea United Bio-Chem Pharmaceutical on December 23, 2014. Korea United Bio-Chem Pharmaceutical recorded total assets of KRW 10.62 billion and net liabilities of KRW 1.3 billion for the year ended December 31, 2013. The Board of Directors of Korea United Bio-Chem Pharmaceutical passed a resolution for the transaction.

Latest news about Korea United Pharm Inc.

Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	23-07-14	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	23-07-14	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	23-07-14	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	23-07-14	CI
Korea United Pharm Inc.'s Equity Buyback announced on July 15, 2022, has expired with 220,980 shares, representing 1.5% for KRW 4,989.48 million.	23-07-13	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022.	22-10-18	CI
Korea United Pharm Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	22-07-15	CI
Korea United Pharm Inc. authorizes a Buyback Plan.	22-07-14	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on October 14, 2016.	16-11-01	CI
Korea United Pharm Inc.'s Equity Buyback announced on October 14, 2016, has closed with 300,000 shares, representing 1.96% for KRW 5,269.23 million.	16-10-30	CI
Korea United Pharm Inc. announces an Equity Buyback for 300,000 shares, for KRW 5,295 million.	16-10-14	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on September 9, 2016.	16-10-14	CI
Korea United Pharm Inc. authorizes a Buyback Plan.	16-10-13	CI
Korea United Pharm Inc.'s Equity Buyback announced on September 9, 2016 has closed with 300,000 shares, representing 1.95% for KRW 5,620.61 million.	16-10-11	CI
Korea United Pharm Inc. announces an Equity Buyback for 300,000 shares.	16-09-09	CI
Korea United Pharm Inc. authorizes a Buyback Plan.	16-09-08	CI
Korea United Pharm Inc. cancelled the sale of 41% stake in Korea United Bio-Chem Pharmaceutical.	15-12-22	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on November 3, 2015.	15-11-22	CI
Korea United Pharm Inc.'s Equity Buyback announced on November 17, 2015 has closed with 30,000 shares, representing 0.19% for KRW 533.29 million.	15-11-16	CI
Korea United Pharm Inc. authorizes a Buyback Plan.	15-11-02	CI
Korea United Pharm Inc. announces an Equity Buyback for 300,000 shares.	15-11-02	CI
Korea United Pharm Inc.(KOSE:A033270) added to Russell Global Index	15-06-29	CI
Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on December 23, 2014.	15-03-15	CI
Korea United Pharm Inc.'s Equity Buyback announced on December 23, 2014 has closed with 200,000 shares, representing 1.26% for KRW 3,264.19 million.	15-03-11	CI
Korea United Pharm Inc. agreed to sell 41% stake in Korea United Bio-Chem Pharmaceutical.	14-12-22	CI

Chart Korea United Pharm Inc.

Duration

Period

More charts

Company Profile

KOREA UNITED PHARM. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Companyâs products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. It also provides active pharmaceutical ingredients (APIs) and various health food products. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KOREA UNITED PHARM INC.	-6.11%	273M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.59%	44.15B
OTSUKA HOLDINGS CO., LTD.	+23.03%	23.02B
SANDOZ GROUP AG	+18.22%	15.33B
CIPLA LIMITED	+12.26%	13.74B
ZYDUS LIFESCIENCES LIMITED	+52.55%	12.16B
ONO PHARMACEUTICAL CO., LTD.	-10.02%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.92%	5.66B

Generic Pharmaceuticals